CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
FRONTIER PAPERS
前沿论文 24
近 5 年肿瘤细胞治疗领域的研究论文，按发表时间由近到远排列。期刊指标供参考，不代表单项研究的证据强度。
实体瘤免疫诊疗一体化：人 IL13Rα2 CAR-T 细胞的体内纵向追踪
Immunotheranostics in Solid Tumors: Longitudinal Tracking of Human IL13Rα2 CAR-T Cells In Vivo.
利用微工程化 3D 肿瘤芯片模型对靶向胶质母细胞瘤的 CAR-T 细胞进行多模态分析
Multimodal profiling of CAR T cells against glioblastoma using a microengineered 3D tumor-on-a-chip model.
计算结构优化增强 IL13Rα2-B7-H3 串联 CAR-T 细胞以克服抗原异质性介导的肿瘤逃逸
Computational structural optimization enhances IL13Rα2 - B7-H3 tandem CAR T cells to overcome antigen-heterogeneity-mediated tumor escape.
靶向 EGFR 和 IL-13Rα2 的脑室内双价 CAR-T 细胞治疗复发胶质母细胞瘤：一项 I 期试验
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.
整合 IL13RA2 的基因工程小鼠模型支持靶向儿童高级别胶质瘤的 CAR-T 细胞
IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas.
拓展 CAR-T 细胞与双特异性 T 细胞衔接器在实体瘤中的治疗覆盖范围
Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors.
胶质母细胞瘤的 CAR-T 细胞治疗：临床试验第一个十年的回顾
CAR T cell therapy for glioblastoma: A review of the first decade of clinical trials.
支持靶向儿童高级别胶质瘤 CAR-T 细胞的 IL13RA2 整合基因工程小鼠模型
IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas.
患者来源胶质母细胞瘤类器官作为实时替身评估临床 CAR-T 细胞治疗反应
Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy.